Increased secretion of TGF‐β1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy

Summary

[1]  V. Sharma,et al.  TGF-β1 DNA Polymorphisms, Protein Levels, and Blood Pressure , 1999 .

[2]  T. Spector,et al.  Genetic control of the circulating concentration of transforming growth factor type beta1. , 1999, Human molecular genetics.

[3]  F. Pociot,et al.  TGF-beta1 gene mutations in insulin-dependent diabetes mellitus and diabetic nephropathy. , 1998, Journal of the American Society of Nephrology : JASN.

[4]  M. Cooper,et al.  Angiotensin converting enzyme inhibition reduces the expression of transforming growth factor‐β1 and type IV collagen in diabetic vasculopathy , 1998, Journal of hypertension.

[5]  K. Sharma,et al.  Transcriptional activation of transforming growth factor-beta1 in mesangial cell culture by high glucose concentration. , 1998, Kidney international.

[6]  H. Parving,et al.  Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients. , 1998, Diabetes.

[7]  G. Jerums,et al.  Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition. , 1998, Diabetes.

[8]  P. Groop,et al.  Urinary excretion of TGF-beta 1, PDGF-BB and fibronectin in insulin-dependent diabetes mellitus patients. , 1997, Kidney international. Supplement.

[9]  P. Groop,et al.  Urinary transforming growth factor-beta 1 in membranous glomerulonephritis. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  M. Daha,et al.  Regulation of Glomerular Epithelial Cell Production of Fibronectin and Transforming Growth Factor-β by High Glucose, Not by Angiotensin II , 1997, Diabetes.

[11]  K. Sharma,et al.  Increased Renal Production of Transforming Growth Factor-β1 in Patients with Type II Diabetes , 1997, Diabetes.

[12]  D. Arveiler,et al.  Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. , 1996, Hypertension.

[13]  K. Sharma,et al.  Hyperglycemia and Diabetic Kidney Disease: The Case for Transforming Growth Factor–β as a Key Mediator , 1995, Diabetes.

[14]  G. Striker,et al.  Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Kagami,et al.  Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. , 1994, The Journal of clinical investigation.

[16]  K. Sharma,et al.  Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. , 1994, The Journal of clinical investigation.

[17]  E Ruoslahti,et al.  Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[18]  L. Groop,et al.  Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. , 1992, BMJ.

[19]  C. Chan,et al.  Characterization of cytokine gene expression in CD4+ and CD8+ T cells after activation with phorbol myristate acetate and phytohaemagglutinin , 1992, Clinical and experimental immunology.

[20]  T. Nakamura,et al.  Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1. , 1992, Kidney international.

[21]  M. Rocco,et al.  Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule. , 1992, Kidney international.

[22]  I. Figari,et al.  The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA. , 1990, Journal of immunology.

[23]  J. Wetzels,et al.  The changing natural history of nephropathy in type I diabetes. , 1986, The American journal of medicine.

[24]  A. Krolewski,et al.  The changing natural history of nephropathy in type I diabetes. , 1985, The American journal of medicine.

[25]  C. Mogensen,et al.  Predicting diabetic nephropathy in insulin-dependent patients. , 1984, The New England journal of medicine.

[26]  H. Keen,et al.  MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS , 1982, The Lancet.